Dataset Information

Cross-Sectional Associations Between Dietary Antioxidant Vitamins C, E and Carotenoid Intakes and Sarcopenic Indices in Women Aged 18-79 Years.

ABSTRACT: The prevalence of sarcopenia is increasing in aging populations, so prevention is critical. Vitamins (A, C, E and carotenoids) modify skeletal muscle via protein and collagen synthesis and anti-inflammatory activities. Previous studies have not investigated intake of these vitamins in relation to sarcopenic indices in both younger and older-aged women. Indices of skeletal muscle mass (as fat-free mass (FFM) relative to body size) were measured using DXA and leg explosive power (LEP) using the Nottingham Power Rig in 2570 women aged 18-79 years. Adjusted measures of skeletal muscle were calculated according to quintiles of vitamin C, E, retinol and carotenoid intake, derived from Food Frequency Questionnaires, after stratification by age. Higher vitamin C intake was associated with significantly higher indices of FFM and LEP, (Q5-Q1?=?2.0-12.8%, P?

SUBMITTER: Welch AA

PROVIDER: S-EPMC7072069 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Cross-Sectional Associations Between Dietary Antioxidant Vitamins C, E and Carotenoid Intakes and Sarcopenic Indices in Women Aged 18-79 Years.

Welch A A AA Jennings A A Kelaiditi E E Skinner J J Steves C J CJ

Calcified tissue international 20191207 4

The prevalence of sarcopenia is increasing in aging populations, so prevention is critical. Vitamins (A, C, E and carotenoids) modify skeletal muscle via protein and collagen synthesis and anti-inflammatory activities. Previous studies have not investigated intake of these vitamins in relation to sarcopenic indices in both younger and older-aged women. Indices of skeletal muscle mass (as fat-free mass (FFM) relative to body size) were measured using DXA and leg explosive power (LEP) using the No ...[more]

PMID: 31813016

Similar Datasets

Project description:IntroductionField tests to estimate maximal oxygen consumption (VO2max) are an alternative to traditional exercise testing methods. Published field tests and their accompanying estimation equations account for up to 80% of the variance in VO2max with an error rate of ~4.5 ml.kg-1.min-1. These tests are limited to very specific age-range populations. The purpose of this study was to create and validate a series of easily administered walking and stepping field equations to predict VO2max across a range of healthy 18-79-year-old adults.MethodsOne-hundred-fifty-seven adults completed a graded maximal exercise test to assess VO2max. Five separate walking and three separate stepping tests of varying durations, number of stages, and intensities were completed. VO2max estimation equations were created using hierarchal multiple regression. Covariates including age, sex, body mass, resting heart rate, distance walked, gait speed, stepping cadence, and recovery heart rate were entered into each model using a stepwise approach. Each full model created had the same base model consisting of age, sex, and body mass. Validity of each model was assessed using a Jackknife cross-validation analysis, and percent bias and root mean square error (RMSE) were calculated.ResultsBase models accounted for ~72% of the total variance of VO2max. Full model variance ranged from ~79-83% and bias was minimal (<±1.0%) across models. RMSE for all models were approximately 4.5 ml.kg-1.min-1. Stepping tests performed better than walking tests by explaining ~2.5% more of the variance and displayed smaller RMSE.ConclusionAll eight models accounted for a large percentage of VO2max variance (~81%) with a RMSE of ~4.5 ml.kg-1.min-1. The variance and level of error of models examined highlight good group mean prediction with greater error expected at the individual level. All the models perform similarly across a broad age range, highlighting flexibility in application of these tests to a more general population.

Project description:Importance:Among older individuals with type 2 diabetes, those with poor health have greater risk and derive less benefit from tight glycemic control with insulin. Objective:To examine whether insulin treatment is used less frequently and discontinued more often among older individuals with poor health compared with those in good health. Design, Setting, and Participants:This longitudinal cohort study included 21?531 individuals with type 2 diabetes followed for up to 4 years starting at age 75 years. Electronic health record data from the Kaiser Permanente Northern California Diabetes Registry was collected to characterize insulin treatment and glycemic control over time. Data were collected from January 1, 2009, through December 31, 2017, and analyzed from February 2, 2018, through June 30, 2019. Exposures:Health status was defined as good (<2 comorbid conditions or 2 comorbidities but physically active), intermediate (>2 comorbidities or 2 comorbidities and no self-reported weekly exercise), or poor (having end-stage pulmonary, cardiac, or renal disease; diagnosis of dementia; or metastatic cancer). Main Outcomes and Measures:Insulin use prevalence at age 75 years and discontinuation among insulin users over the next 4 years (or 6 months prior to death if <4 years). Results:Of 21?531 patients, 10?396 (48.3%) were women, and the mean (SD) age was 75 (0) years. Nearly one-fifth of 75-year-olds (4076 [18.9%]) used insulin. Prevalence and adjusted risk ratios (aRRs) of insulin use at age 75 years were higher in individuals with poor health (29.4%; aRR, 2.03; 95% CI, 1.87-2.20; P?<?.01) and intermediate health (27.5%; aRR, 1.85; 95% CI, 1.74-1.97; P?<?.01) relative to good health (10.5% [reference]). One-third (1335 of 4076 [32.7%]) of insulin users at age 75 years discontinued insulin within 4 years of cohort entry (and at least 6 months prior to death). Likelihood of continued insulin use was higher among individuals in poor health (aRR, 1.47; 95% CI, 1.27-1.67; P?<?.01) and intermediate health (aRR, 1.16; 95% CI, 1.05-1.30; P?<?.01) compared with good health (reference). These same prevalence and discontinuation patterns were present in the subset with tight glycemic control (hemoglobin A1c <7.0%). Conclusions and Relevance:In older individuals with type 2 diabetes, insulin use was most prevalent among those in poor health, whereas subsequent insulin discontinuation after age 75 years was most likely in healthier patients. Changes are needed in current practice to better align with guidelines that recommend reducing treatment intensity as health status declines.

Dataset Information

Cross-Sectional Associations Between Dietary Antioxidant Vitamins C, E and Carotenoid Intakes and Sarcopenic Indices in Women Aged 18-79 Years.

Publications

Cross-Sectional Associations Between Dietary Antioxidant Vitamins C, E and Carotenoid Intakes and Sarcopenic Indices in Women Aged 18-79 Years.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets